Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models.
Li ZJ, He B, Domenichini A, Satiaputra J, Wood KH, Lakhiani DD, Bashaw AA, Nilsson LM, Li J, Bastow ER, Johansson-Percival A, Denisenko E, Forrest AR, Sakaram S, Carretero R, Hämmerling GJ, Nilsson JA, Lee GY, Ganss R.
Li ZJ, et al. Among authors: ganss r.
J Clin Invest. 2024 Sep 17;134(18):e179860. doi: 10.1172/JCI179860.
J Clin Invest. 2024.
PMID: 39286984
Free PMC article.